Medical Xpress October 22, 2024
Taylor & Francis

A new advanced artificial intelligence (AI) tool, developed by renal doctors internationally, represents a significant step forward in predicting and potentially improving outcomes for UK kidney transplant patients.

For patients with late-stage , a can be life-changing, offering the promise of improved survival and a better quality of life compared to other treatment options. But in the UK alone, around 5,000 people are on the waiting list for a kidney transplant, with an average wait time of two to three years for a deceased donor organ.

A team of experts from hospitals across the US and UK have created new software, which could ultimately pave the way for updated kidney allocation policies—potentially leading to better patient outcomes...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Patient / Consumer, Provider, Technology
Scale AI CEO says China has quickly caught the U.S. with the DeepSeek open-source model
Anthropic CEO Sees AI-Powered Advances Doubling Human Lifespans
Health care in transition: Trends shaping 2025
How To Smartly (And Safely) Leverage GenAI In Business
Capcom testing generative AI to manage “tens of thousands of ideas”

Share This Article